FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1901102283> ?p ?o ?g. }

• W1901102283 abstract "Abstract Background Several small receptor tyrosine kinase inhibitors (RTKI) have entered clinical cancer trials alone and in combination with radiotherapy or chemotherapy. The inhibitory spectrum of these compounds is often not restricted to a single target. For example Imatinib/Gleevec (primarily a bcr/abl kinase inhibitor) or SU11248 (mainly a VEGFR inhibitor) are also potent inhibitors of PDGFR and other kinases. We showed previously that PDGF signaling inhibition attenuates radiation-induced lung fibrosis in a mouse model. Here we investigate effects of SU9518, a PDGFR inhibitor combined with ionizing radiation in human primary fibroblasts and endothelial cells in vitro , with a view on utilizing RTKI for antifibrotic therapy. Methods Protein levels of PDGFR-α/-β and phosphorylated PDGFR in fibroblasts were analyzed using western and immunocytochemistry assays. Functional proliferation and clonogenic assays were performed (i) to assess PDGFR-mediated survival and proliferation in fibroblasts and endothelial cells after SU9518 (small molecule inhibitor of PDGF receptor tyrosine kinase); (ii) to test the potency und selectivity of the PDGF RTK inhibitor after stimulation with PDGF isoforms (-AB, -AA, -BB) and VEGF+bFGF. In order to simulate in vivo conditions and to understand the role of radiation-induced paracrine PDGF secretion, co-culture models consisting of fibroblasts and endothelial cells were employed. Results In fibroblasts, radiation markedly activated PDGF signaling as detected by enhanced PDGFR phosphorylation which was potently inhibited by SU9518. In fibroblast clonogenic assay, SU9518 reduced PDGF stimulated fibroblast survival by 57%. Likewise, SU9518 potently inhibited fibroblast and endothelial cell proliferation. In the co-culture model, radiation of endothelial cells and fibroblast cells substantially stimulated proliferation of non irradiated fibroblasts and vice versa. Importantly, the RTK inhibitor significantly inhibited this paracrine radiation-induced fibroblast and endothelial cell activation. Conclusion Radiation-induced autocrine and paracrine PDGF signaling plays an important role in fibroblast and endothelial cell proliferation. SU9518, a PDGFR tyrosine kinase inhibitor, reduces radiation-induced fibroblast and endothelial cell activation. This may explain therapeutic anticancer effects of Imatinib/Gleevec, and at the same time it could open a way of attenuating radiation-induced fibrosis." @default.
• W1901102283 created "2016-06-24" @default.
• W1901102283 creator A5012670084 @default.
• W1901102283 creator A5018890850 @default.
• W1901102283 creator A5027878263 @default.
• W1901102283 creator A5029478371 @default.
• W1901102283 creator A5047716489 @default.
• W1901102283 creator A5072040768 @default.
• W1901102283 creator A5073316865 @default.
• W1901102283 creator A5075116222 @default.
• W1901102283 creator A5078003238 @default.
• W1901102283 creator A5086658735 @default.
• W1901102283 date "2006-03-24" @default.
• W1901102283 modified "2023-10-17" @default.
• W1901102283 title "Small molecule receptor tyrosine kinase inhibitor of platelet-derived growth factor signaling (SU9518) modifies radiation response in fibroblasts and endothelial cells" @default.
• W1901102283 cites W1507887565 @default.
• W1901102283 cites W1575891190 @default.
• W1901102283 cites W1710057076 @default.
• W1901102283 cites W1841849374 @default.
• W1901102283 cites W1942354720 @default.
• W1901102283 cites W1969921590 @default.
• W1901102283 cites W1972607007 @default.
• W1901102283 cites W1972644785 @default.
• W1901102283 cites W1973631902 @default.
• W1901102283 cites W1981330583 @default.
• W1901102283 cites W1986043499 @default.
• W1901102283 cites W1987373390 @default.
• W1901102283 cites W1989241188 @default.
• W1901102283 cites W1990343422 @default.
• W1901102283 cites W2000946764 @default.
• W1901102283 cites W2001690919 @default.
• W1901102283 cites W2004078164 @default.
• W1901102283 cites W2009639116 @default.
• W1901102283 cites W2012498955 @default.
• W1901102283 cites W2021218223 @default.
• W1901102283 cites W2034885481 @default.
• W1901102283 cites W2053806341 @default.
• W1901102283 cites W2058719558 @default.
• W1901102283 cites W2079235460 @default.
• W1901102283 cites W2085295620 @default.
• W1901102283 cites W2090765344 @default.
• W1901102283 cites W2104106770 @default.
• W1901102283 cites W2105086598 @default.
• W1901102283 cites W2106979625 @default.
• W1901102283 cites W2110121929 @default.
• W1901102283 cites W2112302625 @default.
• W1901102283 cites W2116008315 @default.
• W1901102283 cites W2125830930 @default.
• W1901102283 cites W2133500765 @default.
• W1901102283 cites W2135200381 @default.
• W1901102283 cites W2139676810 @default.
• W1901102283 cites W2145106519 @default.
• W1901102283 cites W2165125367 @default.
• W1901102283 cites W2227847667 @default.
• W1901102283 cites W32471076 @default.
• W1901102283 doi "https://doi.org/10.1186/1471-2407-6-79" @default.
• W1901102283 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1458351" @default.
• W1901102283 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16556328" @default.
• W1901102283 hasPublicationYear "2006" @default.
• W1901102283 type Work @default.
• W1901102283 sameAs 1901102283 @default.
• W1901102283 citedByCount "44" @default.
• W1901102283 countsByYear W19011022832012 @default.
• W1901102283 countsByYear W19011022832013 @default.
• W1901102283 countsByYear W19011022832014 @default.
• W1901102283 countsByYear W19011022832015 @default.
• W1901102283 countsByYear W19011022832018 @default.
• W1901102283 countsByYear W19011022832019 @default.
• W1901102283 countsByYear W19011022832020 @default.
• W1901102283 countsByYear W19011022832021 @default.
• W1901102283 countsByYear W19011022832022 @default.
• W1901102283 crossrefType "journal-article" @default.
• W1901102283 hasAuthorship W1901102283A5012670084 @default.
• W1901102283 hasAuthorship W1901102283A5018890850 @default.
• W1901102283 hasAuthorship W1901102283A5027878263 @default.
• W1901102283 hasAuthorship W1901102283A5029478371 @default.
• W1901102283 hasAuthorship W1901102283A5047716489 @default.
• W1901102283 hasAuthorship W1901102283A5072040768 @default.
• W1901102283 hasAuthorship W1901102283A5073316865 @default.
• W1901102283 hasAuthorship W1901102283A5075116222 @default.
• W1901102283 hasAuthorship W1901102283A5078003238 @default.
• W1901102283 hasAuthorship W1901102283A5086658735 @default.
• W1901102283 hasBestOaLocation W19011022831 @default.
• W1901102283 hasConcept C101544691 @default.
• W1901102283 hasConcept C121608353 @default.
• W1901102283 hasConcept C126322002 @default.
• W1901102283 hasConcept C170493617 @default.
• W1901102283 hasConcept C180361614 @default.
• W1901102283 hasConcept C185592680 @default.
• W1901102283 hasConcept C2775960820 @default.
• W1901102283 hasConcept C2778820342 @default.
• W1901102283 hasConcept C2781294074 @default.
• W1901102283 hasConcept C42362537 @default.
• W1901102283 hasConcept C502942594 @default.
• W1901102283 hasConcept C55493867 @default.
• W1901102283 hasConcept C62478195 @default.
• W1901102283 hasConcept C71924100 @default.
• W1901102283 hasConcept C86803240 @default.
• W1901102283 hasConcept C95444343 @default.
• W1901102283 hasConceptScore W1901102283C101544691 @default.

• next